IP Library Granted Patent US 7,932,388
Granted Patent B2
US 7,932,388 · App. 12/001,734 · Granted Apr 26, 2011

Isotopically enriched N-substituted piperazines and methods for the preparation thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,932,388
App. No.
12/001,734
Granted
Apr 26, 2011
Kind
B2
Abstract

In some embodiments, this invention pertains to isotopically enriched N-substituted piperazines. In some embodiments, this invention pertains to methods for the preparation of isotopically enriched N-substituted piperazines.

Claims (21)

1. An isotopically enriched N-substituted piperazine compound of the formula:

, or a salt thereof, comprising one or more heavy atom isotopes, wherein;

Y is a straight chain or branched C1-C6 alkyl group or a straight chain or branched C1-C6 alkyl ether group wherein the carbon atoms of the alkyl group or alkyl ether group each independently comprise linked hydrogen, deuterium or fluorine atoms; and

each Z is independently hydrogen, fluorine, chlorine, bromine, iodine, an amino acid side chain, a straight chain or branched C1-C6 alkyl group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently comprise linked hydrogen or fluorine atoms, a straight chain or branched C1-C6 alkyl ether group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently comprise linked hydrogen or fluorine atoms or a straight chain or branched C1-C6 alkoxy group that may optionally contain a substituted or unsubstituted aryl group wherein the carbon atoms of the alkyl and aryl groups each independently comprise linked hydrogen or fluorine atoms;

wherein the N-methyl piperazine is isotopically enriched with either of 13 C and/or 15 N.

2. The compound of claim 1 , wherein the N-substituted piperazine is isotopically enriched with two or more heavy atom isotopes.

3. The compound of claim 1 , wherein the N-substituted piperazine is isotopically enriched with three or more heavy atom isotopes.

4. The compound of claim 1 , wherein the N-substituted piperazine is isotopically enriched with four or more heavy atom isotopes.

5. The compound of claim 1 , wherein each Z is independently hydrogen, fluorine, chlorine, bromine or iodine.

6. The compound of claim 1 , wherein each Z is independently hydrogen, methyl or methoxy.

7. The compound of claim 1 , wherein Y is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl or tert-butyl.

8. The compound of claim 1 , wherein each nitrogen atom of the piperazine ring is independently 14 N or 15 N.

9. The compound of claim 1 of the formula:

10. The compound of claim 9 , wherein the compound is a mono-TFA salt, a mono-HCl salt, a bis-TFA salt or a bis-HCl salt.

11. The compound of claim 9 , wherein each incorporated heavy atom isotope is present in at least 80 percent isotopic purity.

12. The compound of claim 9 , wherein each incorporated heavy atom isotope is present in at least 93 percent isotopic purity.

13. The compound of claim 9 , wherein each incorporated heavy atom isotope is present in at least 96 percent isotopic purity.

14. The compound of claim 1 , wherein the N-substituted piperazine is a mono-TFA salt, a mono-HCl salt, a bis-HCl salt or a bis-TFA salt.

15. The compound of claim 1 , wherein each incorporated heavy atom isotope is present in at least 80 percent isotopic purity.

16. The compound of claim 1 , wherein each incorporated heavy atom isotope is present in at least 93 percent isotopic purity.

17. The compound of claim 1 , wherein each incorporated heavy atom isotope is present in at least 96 percent isotopic purity.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE THE SECURITY INTEREST. Recorded Mar 4, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 038006/0883 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2010
From: APPLIED BIOSYSTEMS, LLC
To: DH TECHNOLOGIES DEVELOPMENT PTE. LTD.
Reel/Frame 024534/0736 →
RELEASE OF SECURITY INTEREST Recorded Mar 31, 2010
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 024160/0955 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →